All Blogs

May 31, 2021

Adult-onset Still’s Disease (AoSD), alternatively known as systemic-onset juvenile idiopathic arthritis, is a rare systemic inflammatory disorder of unknown etiology. There are three main patterns of AoSD’s clinical course: monophasic, intermittent, and chronic.  Although there is an approximately equal distri...

May 27, 2021

Pieris Pharmaceuticals declares Respiratory and Ophthalmology deal with Genentech Pieris, a clinical-stage biotechnology company, declared that it has entered into a multi-program research collaboration and license collaboration with Genentech, a member of the Roche Group, to discover, develop and commercialise ...

May 28, 2021

An infusion pump is a medical device that is employed in the administration of fluids such as nutrients and medications into a patient's body in controlled amounts. Infusion pumps are extensively used in clinical settings such as hospitals, nursing homes, and homes. There are many types of infusion pumps, including...

May 26, 2021

Today, the increasing prevalence of Chronic Respiratory Diseases (CRDs) is one of the leading health challenges worldwide. CRDs affect hundreds of millions of people and cause huge mortality, morbidity, immense socio-economic burden, and disability-adjusted life years (DALYs).  Over the past few decades, si...

May 25, 2021

TLX66 Meets Study Objectives, Holding Out in AL Amyloidosis Telix Pharmaceuticals reported the results from the TRALA trial (Targeted Radiotherapy for AL Amyloidosis), a Phase I/IIa trial evaluating the safety and toxicity of TLX66 as the sole bone marrow conditioning agent prior to autologous hematopoietic stem...

May 24, 2021

Over the last decades, organ transplantation has become the leading treatment option for patients with last-stage organ failure. However, although it has significantly reduced the mortality rate, specifically in life-threatening diseases such as end-stage kidney failure, recognition and eventual destruction of well...

May 21, 2021

Hearing loss is observed to be the most common sensory disorder. Hearing loss is found to be an etiologically diverse condition that is accompanied by various disease-related complications and major clinical, social, and implications affecting the quality of life. Approximately 50% to 60% of hearing loss patients a...

May 20, 2021

HCmed Signs a Global Development Agreement with CSL Behring to develop a combination product On May 04, 2021, HCmed has announced the start of a strategic partnership with global biotherapeutics leader CSL Behring to collaboratively develop CSL Behring's plasma-derived immunoglobulin administered via HCmed’s new...

May 19, 2021

Substance Use Disorder today is one of the most serious health concerns in almost every country. As per the Substance Abuse and Mental Health Services Administration (SAMHSA), “In 2018, approximately 20.3 million people aged 12 or older had a SUD in the past year in the US”. Of the total cases around 14.8 million h...

May 18, 2021

InnoCare Receives Go-ahead for Clinical Trial of TYK2 Inhibitor ICP-332 in China InnoCare, a biopharma firm developing novel therapies for the treatment of cancer and autoimmune diseases, today announced the approval of Phase I clinical trial of its novel TYK2 (Tyrosine Kinase 2) inhibitor, ICP-332, by the China...